SEARCH TIPS
Search term too short
Invalid text in search term. Try again
ADVANCED SEARCH
DOCKET SEARCH
Search
Toggle navigation
OPINIONS
Opinions of the Court
Opinions Relating to Orders
In-Chambers Opinions
U. S. Reports
Online Sources Cited in Opinions
Media Files Cited in Opinions
Case Citation Finder
FILING & RULES
Electronic Filing
Rules and Guidance
Supreme Court Bar
ORAL ARGUMENTS
Argument Transcripts
Argument Audio
Calendars and Lists
Courtroom Seating
CASE DOCUMENTS
Docket Search
Orders of the Court
Orders by Circuit
Granted/Noted Cases List
Journal
Original Jurisdiction Records & Briefs
NEWS MEDIA
Services for News Media
Press Releases
Media Advisories
Press Credentials
Speeches
A Reporter's Guide to Applications
Chief Justice's Year-End Reports on the Federal Judiciary
ABOUT
Justices
Supreme Court at Work
Code of Conduct for Justices
History and Traditions
The Supreme Court Building
Building Regulations
Frequently Asked Questions
VISIT
Hours & Directions
Prohibited Items
Visitor Guidelines
Accessibility
Maps & Guides
Courtroom Lectures
Exhibitions
Group Visits
Activities for Students & Families
Café & Building Amenities
Home
>
Search Results
Docket for 22A272
Search documents in this case:
Search
No. 22A272
Title:
Novartis Pharmaceuticals Corporation, Applicant
v.
HEC Pharm Co., Ltd., et al.
Docketed:
September 29, 2022
Lower Ct:
United States Court of Appeals for the Federal Circuit
Case Numbers:
(2021-1070)
Proceedings and Orders
Sep 28 2022
Application (22A272) for a stay, submitted to The Chief Justice.
Main Document
Lower Court Orders/Opinions
Proof of Service
Sep 29 2022
Upon consideration of the application of counsel for the applicant, it is ordered that the mandate of the United States Court of Appeals for the Federal Circuit, case No. 2021-1070, is hereby stayed pending further order of The Chief Justice or of the Court. It is further ordered that a response to the application be filed on or before Wednesday, October 5, 2022, by noon (EDT).
Oct 05 2022
Response to application from respondent HEC Pharm Co., Ltd., et al. filed.
Main Document
Main Document
Proof of Service
Oct 07 2022
Reply of applicant Novartis Pharmaceuticals Corporation filed.
Reply
Proof of Service
Oct 11 2022
Supplemental letter from applicant filed.
Main Document
Other
Oct 11 2022
Supplemental letter from respondents filed.
Main Document
Oct 13 2022
Application (22A272) referred to the Court.
Oct 13 2022
Application (22A272) for stay of the mandate presented to The Chief Justice and by him referred to the Court is denied. The order heretofore entered by The Chief Justice is vacated.
Attorneys
Attorneys for Petitioners
William McGinley Jay
Counsel of Record
Goodwin Procter, LLP
1900 N Street, N.W.
Washington, DC 20036
WJay@goodwinlaw.com
Ph: 2023464190
Party name: Novartis Pharmaceuticals Corporation
Attorneys for Respondents
Peter K. Stris
Counsel of Record
Stris and Maher LLP
777 S. Figueroa Street
Suite 3850
Los Angeles, CA 90017
pstris@stris.com
Ph: 2139956800
Party name: HEC Pharm Co., Ltd., et al.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##